Lombard Odier Asset Management (USA)’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-24,276	Closed	-$1.3M	–	284
2016 Q1	$1.3M	Sell	24,276 -17,037	-41%	-$1.26M	0.18%	122
2015 Q4	$4.67M	Sell	41,313 -18,687	-31%	-$2.06M	0.45%	88
2015 Q3	$7.06M	Sell	60,000 -90,000	-60%	-$11.8M	0.62%	53
2015 Q2	$11.6M	Sell	150,000 -80,223	-35%	-$5.26M	0.83%	27
2015 Q1	$13.3M	Sell	230,223 -519,777	-69%	-$22.1M	1.06%	24
2014 Q4	$24.2M	Sell	750,000 -250,000	-25%	-$7.5M	1.66%	8
2014 Q3	$24.5M	Sell	1,000,000 -285,000	-22%	-$5.79M	1.69%	5
2014 Q2	$22.8M	Sell	1,285,000 -90,000	-7%	-$1.45M	1.2%	11
2014 Q1	$27.5M	Sell	1,375,000 -74,000	-5%	-$1.43M	1.06%	30
2013 Q4	$24.3M	Sell	1,449,000 -251,000	-15%	-$3.47M	1.04%	33
2013 Q3	$18.1M	Sell	1,700,000 -215,000	-11%	-$1.88M	0.91%	36
2013 Q2	$10.7M	Buy	+1,915,000	New	+$11.6M	0.6%	62

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s ANAC Position: Q2 2016 in Review

Lombard Odier Asset Management (USA) sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 24,276 shares — an estimated $1.3M sold.

Lombard Odier Asset Management (USA) first reported a position in ANAC in Q2 2013 and held it in 12 quarters. The position peaked at $27.5M in Q1 2014. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Lombard Odier Asset Management (USA) reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 24,276 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $1.3M.
Lombard Odier Asset Management (USA) first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 12 quarters.
Lombard Odier Asset Management (USA)'s ANACOR PHARMACEUTICALS INC COM position peaked at $27.5M in Q1 2014.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q2 2016, filed 15 Aug 2016.